Rx price increases in 2021 lower than 2020, but not fully warranted: Study

Pharmaceutical price increases 2021 that were behind an $805 million increase in U.S. spending from the prior year were not supported by clinical evidence, an influential U.S. pricing research firm says, reports Reuters. The Institute for Clinical and Economic Review said the spending increase in 2021 was still less than the $1.67 billion rise in the previous year.